… results in pre-clinical trials. Relevance to Diagnosis/Treatment of Parkinson's Disease: Levodopa is the most … interfere with the anti-parkinsonian effect of the treatment. No serious side effects were recorded. The … Complications of Treatment …

… and amantadine proved to be better than the benefits from either one alone even if the individual effects were … the study and recruiting subjects with dyskinesia, ranging from mild to severe, who have been on stable doses of …

… Dry Powder-Based Delivery of Intrapulmonary Levodopa as a Treatment for Motor Fluctuations in Parkinson's Disease … proprietary inhaled levodopa, which is being developed as a treatment to provide rapid relief of intermittent "off" … is part of an integrated project plan to develop a new treatment for Parkinson’s patients to address an unmet …

… unique to each person . As symptoms and progression vary from person to person, neither you nor your doctor can … for Parkinson's Research has a policy of refraining from advocating, endorsing or promoting any drug …

… build alpha-synuclein with or without O-GlcNAc modification from the ground up, resulting in highly pure proteins. With … allow us to isolate the effect of O-GlcNAc modification from confounding factors that may arise in cell- or …

… available for this aspect of the disease. Exciting results from laboratory experiments suggest a class of medicines … PD in the group treated with glitazones. The protection from PD was strongest during glitazone treatment, with …